COPD International   Your Support Network

You can learn to control this disease instead of letting it control you!

 

Return To The Main Library         <<<<>>>>         Return To The HomePage

 
 
SafetyAlerts
October 3, 2002

Pfizer Has Recalled Benadryl Allergy/Sinus Headache Caplets

(SafetyAlerts) - The Food and Drug Administration (FDA) has released the following information.

PRODUCT
Benadryl Allergy/Sinus Headache Caplets co-packaged with a Bonus 4 mL bottle of Visine Tears (Diphenhydramine Hydrochloride 12.5 mg, Pseudoephedrine Hydrochloride 30 mg, Acetaminophen 500 mg), 24 count package. Recall # D-415-2.


CODES
Codes: Lot Numbers:
01222CD01 Exp Date: 4/2003
01222CM01 "
01322CD01 "
01322CM01 "
01422CN01 "
01522CD01 "
01522CN01 "

RECALLING FIRM/MANUFACTURER
Recalling Firm: Pfizer Consumer Healthcare R&D Morris Plains, NJ., by letter on June 11, 2002.
Manufacturer: Pfizer, Inc., Vega Baja, PR. Firm initiated recall ongoing.

REASON
Mispackaged; promotional packages labeled as containing Benadryl Allergy/Sinus Headache Caplets co-packaged with a bonus 4mL sample of Visine Tears may actually contain Benadryl Severe Allergy/Sinus Headache Caplets.

VOLUME OF PRODUCT IN COMMERCE
2270 boxes of 24 caplets.

DISTRIBUTION
AR.

Send mail to: Webmaster@COPD-International.com with questions
or comments about this web site.
Copyright © 2002-2004 ----- COPD-International.com
Last modified:
October 11, 2002
Disclaimer